Amedisys (NASDAQ:AMED) Hits New 12-Month High at $97.42

Amedisys, Inc. (NASDAQ:AMED)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as $97.42 and last traded at $97.18, with a volume of 603345 shares trading hands. The stock had previously closed at $96.74.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on AMED shares. Royal Bank of Canada boosted their target price on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. William Blair downgraded Amedisys from an “outperform” rating to a “market perform” rating in a research note on Monday. StockNews.com upgraded Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Raymond James restated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a report on Thursday, April 25th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $100.67.

Amedisys Price Performance

The business has a 50-day moving average price of $93.55 and a 200 day moving average price of $93.51. The stock has a market cap of $3.17 billion, a PE ratio of -152.03, a PEG ratio of 2.39 and a beta of 0.79. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, beating the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. During the same period in the prior year, the firm earned $1.00 earnings per share. The company’s revenue was up 2.7% compared to the same quarter last year. As a group, research analysts forecast that Amedisys, Inc. will post 4.57 earnings per share for the current fiscal year.

Institutional Trading of Amedisys

A number of institutional investors have recently added to or reduced their stakes in the stock. Retirement Systems of Alabama increased its position in shares of Amedisys by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 40,871 shares of the health services provider’s stock valued at $3,885,000 after buying an additional 125 shares during the period. Treasurer of the State of North Carolina increased its holdings in shares of Amedisys by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock worth $1,350,000 after purchasing an additional 140 shares during the period. Louisiana State Employees Retirement System boosted its stake in Amedisys by 2.2% during the first quarter. Louisiana State Employees Retirement System now owns 9,400 shares of the health services provider’s stock valued at $866,000 after buying an additional 200 shares during the period. Bridge City Capital LLC boosted its position in shares of Amedisys by 0.8% during the 1st quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock valued at $2,752,000 after acquiring an additional 231 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Amedisys by 0.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock valued at $2,876,000 after acquiring an additional 255 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.